Persantine IV
Clues to Congenital Heart Disease »
"A large-scale genomic analysis found that non-inherited mutations in hundreds of genes together account for about 1 in 10 cases of severe congenital heart defects. The findings bring us closer to understanding the most common type of birth defect"...
Persantine IV
Please Note: This Brand Name drug is no longer available in the US.(Generic versions may still be available.)
IV PERSANTINE®
(dipyridamole USP) Prescribing Information
DRUG DESCRIPTION
Persantine® (dipyridamole USP) for intravenous injection is a coronary vasodilator described as 2,6-Bis(diethanolamino)-4,8-dipiperidinopy-rimido [5,4-d]-pyrimidine.
Dipyridamole in solution is an odorless, pale yellow liquid which can be diluted in normal saline and dextrose and water for intravenous administration.
IV Persantine® as a sterile solution for intravenous administration contains:
Active Ingredient VIAL10 mL: dipyridamole USP 50 mg.
Inactive Ingredients VIAL10 mL: polyethylene glycol 600 500 mg, tartaric acid 20 mg. pH is adjusted to 2.7 ±0.5 with hydrochloric acid.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Persantine IV Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Heart Health
Get the latest treatment options.
Updated & New
